Meet the speakers of CityU – AFCR Symposium
CityU-AFCR Symposium on Precision Medicine and Digital Medicine will go on from 12-13 September as part of BIOHK2024.
The symposium will showcase presentations by BRACE award winners and experts in precision medicine, providing a dynamic platform for the exchange of innovative ideas and fostering a collaborative environment for advancements in the biotechnology field.
One of the Organizing Commitee- Chairs is Sujuan Ba, she is also going to be among the speakers.
Dr. Sujuan Ba is a prominent leader in the field of cancer research and a co-founder of several organizations that support innovative and collaborative cancer research projects. She is the President and CEO, Founder of the Asian Fund for Cancer Research. She also serves as the President and CEO of the National Foundation for Cancer Research, the Co-founder and CEO of the AIM-HI Accelerator Fund, and the Co-Founder and Board Member of the Global Coalition for Adaptive Research.
She is one of the instrumental leaders in establishing GBM AGILE, the first-ever paradigm-shifting adaptive clinical trial platform for brain cancer and other rare cancers. She is also a scientific advisor and a board member for more than half a dozen oncology start-ups.
Dr. Ba has led the establishment of NFCR’s annual Szent-Györgyi Prize for Progress in Cancer Research, an international prize recognizing outstanding scientific achievement in the war against cancer, and has served continuously as co-chair of the Prize Selection Committee since 2006. The prize has now grown into one of the premier cancer research awards in the world.
Dr. Ba received the Leadership Award for Global Advocate for Cancer Research from HKBIO in 2023. Dr. Ba also received the NBC4 WORKING 4 THE COMMUNITY Award in 2019, recognizing her outstanding achievements as a scientist, leader, and role model in the STEM field. Dr. Ba also received the inaugural Outstanding Achievement Award from the Society for Neuro-Oncology of the Chinese Medical Doctor Association for her outstanding contribution to international cooperation in 2017.
She was named one of the “Top 300 Women Leaders in Global Health” in 2015 by the Graduate Institute of International and Development Studies’ Global Health Programme.
Dr. Ba received her B.S. in radiochemistry from Peking University and her Ph.D. in chemistry from the University of Pennsylvania.
Stay tuned for more information about CityU-AFCR Symposium on OncoDaily